G'day fellow IMU holders !
Does anyone with knowledge/experience in this kind of clinical trials , knows what occurs when the 100s of doctors around the globe are trying to get their patients enrolled in the trial in such numbers that far exceeds the numbers initially planned for the trial ??
I think that this could be a likely scenario if everything keeps progressing as expected ( replicating in humans similar effects to the ones observed in animals, or even just close), the we find ourselves with 1000s of patients instead of the 100s planned
Could we be qualified as orphan drug half way of the trial? If results are positive. These people would die soon (few moths or weeks) otherwise...
How this accelerated transition from clinical trial to Commercial Drug works ??
I'm electric engineer, so no knowledge in the field at all, other than as everyone here seeing cancer affecting relatives and friends.
Have a nice Sunday !
- Forums
- ASX - By Stock
- IMU
- Ann: FDA clears Imugene IND for onCARlytics first-in-class study
Ann: FDA clears Imugene IND for onCARlytics first-in-class study, page-148
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
IMU (ASX) Chart |